Mochi Health

Mochi Health is a San Francisco-based telehealth company founded in 2021 that focuses specifically on obesity medicine. It's one of the small set of programs built from scratch around GLP-1 therapy rather than as a weight-loss add-on to a general telehealth service.

The core product is a $99/month flat-fee membership. Medication is separate — you pay either your insurance copay or a cash price through Mochi's affiliated pharmacies. There's no per-visit billing, no surprise labs, no provider upsells.

What distinguishes Mochi from cheaper compounded-only programs: real insurance work. When you sign up, a coverage specialist reviews your plan's formulary and builds a prior authorization packet tailored to your plan's criteria. When PA is required (which is most commercial plans for Zepbound, Wegovy, or Saxenda), Mochi submits it and appeals denials. This alone is worth substantially more than the $99 for covered patients.

The intake is the longest in the category — about 25 minutes — and that's a feature, not a bug. Mochi collects BMI, weight history, prior weight-loss attempts, comorbidities (hypertension, prediabetes, sleep apnea), medication list, and insurance details. A licensed physician reviews within 24–48 hours and either approves a prescription plan or requests labs first.

If labs are needed (usually HbA1c, lipid panel, TSH, basic metabolic panel), you're routed to Quest or LabCorp with an electronic order. Cash price is about $35 with GoodRx; insurance usually covers. You book online, walk in, and results typically arrive within 3–5 business days.

Once approved, your coverage specialist submits the PA (for commercial insurance) or dispatches the cash prescription to LillyDirect, NovoCare Pharmacy, or a 503A compounding pharmacy depending on what you've chosen. Typical total timeline: 7–14 days from signup to medication in hand. Faster if you skip labs or have recent bloodwork to upload.

Mochi's prescribers are U.S. board-certified physicians (MDs and DOs), plus a mix of NPs and PAs under physician supervision. The staff/patient ratio is tight enough that you typically keep the same prescriber across visits — unusual at this price point.

The dietitian network is credentialed RDs. Every member gets a 30-minute intake session with a dietitian; follow-ups are every 4 weeks, 20 minutes each. Topics typically covered: protein targets (1.2–1.6 g/kg ideal body weight), fiber, resistance training, hydration during titration, and — by month 3 — strategies for plateau management.

What's missing: no behavioral health component, no CGM integration, no in-person option. For patients who need more intensive psychological support (binge eating, long-standing disordered eating), Form Health is the stronger clinical choice.

The $99 membership is the top-line number. Total cost depends on whether you use insurance and which medication you're on.

With commercial insurance, Zepbound or Wegovy covered + savings card: ~$99 (membership) + $25 (drug copay) = $124/month all-in. This is as cheap as quality GLP-1 care gets in 2026.

Self-pay brand-name Zepbound via LillyDirect: $99 + $349 = $448/month.

Self-pay compounded tirzepatide or semaglutide: $99 + $180–$250 = $279–$349/month. Compounded quality varies; Mochi uses 503A pharmacies with documented CoAs.

Medicare or Medicaid patients: Mochi Care Navigator can sometimes unlock the Wegovy CV indication pathway (if you have established CVD) or state Medicaid coverage where it exists. If neither applies, cash or compounded paths.

vs. Form Health: Form Health is the stronger pure clinical play — more intensive physician involvement, behavioral coaching built in. Mochi is cheaper and better at insurance navigation. If cost matters, pick Mochi; if clinical depth matters, Form.

vs. Ro: Ro is faster (2–5 days to first dose) and has broader medication catalog. Mochi is cheaper and better at insurance. If speed is the priority and you'll pay cash, Ro; otherwise Mochi.

vs. Hims: Not really comparable. Hims is minimal-support cash program; Mochi is full-service with insurance navigation.

vs. TrimRx: TrimRx is cheaper for strict cash-pay compounded GLP-1s. Mochi is the better pick for anyone who might qualify for insurance — the PA work pays for itself within 1–2 months.

For the median person shopping for a GLP-1 telehealth program in 2026 — commercially insured, wants brand-name medication, values a clinical team over a fulfillment engine — Mochi Health is our top pick. The $99 flat fee with real insurance work builds to one of the lowest effective costs in the category, and the clinical team is legitimate.

Where Mochi isn't the right answer: if you need speed (Ro), if you want intensive behavioral coaching (Form Health), if you're paying cash and only cash (TrimRx), or if you're on Medicaid in a restrictive state (MyStart Health).